Northrop Grumman's stock dropped 16%, prompting an upgrade to Strong Buy as it now trades below intrinsic value. The company reported strong Q1 2026 results with double-digit organic sales growth but limited margin expansion due to inefficiencies and development programs. Despite the positive earnings beat, the 2026 guidance remains steady with sales expected between $43.5–$44 billion and EPS at $27.40–$27.90, reflecting a year of ramp-up rather than breakout growth. The valuation gap with peers and stable long-term outlook support a price target of $711.67, suggesting 21% upside potential.
Northrop Grumman has started construction on a new building at its Roy Innovation Center in Utah to support the U.S. Air Force Sentinel Intercontinental Ballistic Missile program and other aerospace missions. This expansion will add to the existing c...
Small-cap stocks in the U.S. market continue to be the most undervalued segment, even after their best first-half performance in over 30 years, according to Morningstar's Q3 2026 outlook. The overall market shows a modest 8% discount to fair value, b...
